Cargando…
The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction
INTRODUCTION: Although blinding is a methodologic safeguard to ensure obtaining comparability of groups in a clinical trial, it is very difficult to maintain blinding from the beginning to the end of a study. The aim of the study was to see how proper blinding of both participants and treatment prov...
Autores principales: | Jeong, Hyunsuk, Yim, Hyeon Woo, Cho, Youngseung, Park, Hun Jun, Jeong, Sona, Kim, Hyun-bin, Hong, Wonhee, Kim, Heejung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854784/ https://www.ncbi.nlm.nih.gov/pubmed/23849537 http://dx.doi.org/10.1186/scrt233 |
Ejemplares similares
-
Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis
por: Jeong, Hyunsuk, et al.
Publicado: (2018) -
Bone marrow mononuclear cells and acute myocardial infarction
por: Arnous, Samer, et al.
Publicado: (2012) -
Autologous Bone Marrow Mononuclear Cells (BMMC)-Associated Anti-Inflammatory Nanoparticles for Cardiac Repair after Myocardial Infarction
por: Uemura, Laercio, et al.
Publicado: (2022) -
Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2009) -
Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells
por: Poole, Joseph C., et al.
Publicado: (2013)